Zobrazeno 1 - 10
of 69
pro vyhledávání: '"M P, Sormani"'
Autor:
H. Vrenken, M. Battaglini, M. L. de Vos, G. J. Nagtegaal, B. C. A. Teixeira, A. Seitzinger, D. Jack, M. P. Sormani, B. M. J. Uitdehaag, A. Versteeg, G. Comi, L. Kappos, N. De Stefano, F. Barkhof
Publikováno v:
Vrenken, H, Battaglini, M, de Vos, M L, Nagtegaal, G J, Teixeira, B C A, Seitzinger, A, Jack, D, Sormani, M P, Uitdehaag, B M J, Versteeg, A, Comi, G, Kappos, L, de Stefano, N & Barkhof, F 2023, ' Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a ', Journal of Neurology, vol. 270, no. 4, pp. 2271-2282 . https://doi.org/10.1007/s00415-022-11554-5
Journal of Neurology, 270(4), 2271-2282. D. Steinkopff-Verlag
Journal of Neurology, 270(4), 2271-2282. D. Steinkopff-Verlag
Objective Evaluate the effect of subcutaneous interferon β-1a (sc IFN β-1a) versus placebo on the evolution of T1-weighted MRI lesions and central brain atrophy in in patients with a first clinical demyelinating event (FCDE). Methods Post hoc analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a014c8dbb91fb175353e359ef889c06
https://research.vumc.nl/en/publications/8333bc63-4499-4df6-ac17-b62e263ea3a8
https://research.vumc.nl/en/publications/8333bc63-4499-4df6-ac17-b62e263ea3a8
Autor:
I. Schiavetti, L. Barcellini, C. Lapucci, F. Tazza, M. Cellerino, E. Capello, D. Franciotta, M. Inglese, M. P. Sormani, A. Uccelli, A. Laroni
Treatment with fingolimod for multiple sclerosis (MS) reduces the efficacy of COVID-19 vaccination. We evaluated by a multivariate linear regression model whether main lymphocyte subsets and demographic feature correlated to the subsequent increase i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06287e88a68089cff7916626bc6eb7ec
https://doi.org/10.1101/2022.07.02.22277178
https://doi.org/10.1101/2022.07.02.22277178
Autor:
Chiara Zecca, C. Lienerth, Alessandro Cianfoni, A. Kaelin-Lang, Luca Roccatagliata, Claudio Gobbi, Emanuele Pravatà, R. Sacco, L. Carmisciano, M. P. Sormani
Publikováno v:
AJNR Am J Neuroradiol
BACKGROUND AND PURPOSE: Demyelinating lesions in the anterior visual pathways represent an underestimated marker of disease dissemination in patients with MS. We prospectively investigated whether a dedicated high-resolution MR imaging technique, the
Autor:
Caterina Lapucci, Luca Carmisciano, M. Inglese, Alice Laroni, Antonio Uccelli, L. Nesi, Maria Cellerino, E. Gallo, Laura Filippi, Matteo Pardini, Elvira Sbragia, M. P. Sormani, Alessio Signori, Giovanni Novi, Riccardo Meli
Background and purpose The importance of upper limb function in multiple sclerosis (MS) is increasingly recognized, especially for the evaluation of patients with progressive MS with reduced mobility. Two sensor-engineered gloves, able to measure qua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97b06135332f77b7db0117d5d963c29c
http://hdl.handle.net/11567/1019793
http://hdl.handle.net/11567/1019793
Autor:
Marco Battaglini, A De Leucio, Christine Hicking, M. P. Sormani, N. De Stefano, Fernando Dangond, Antonio Giorgio, Gavin Giovannoni
Publikováno v:
Multiple Sclerosis (Houndmills, Basingstoke, England)
Background: Neuroimaging studies have used magnetic resonance imaging-derived methods to assess brain volume loss in multiple sclerosis (MS) as a reliable measure of diffuse tissue damage. Methods: In the CLARITY study ( ClinicalTrials.gov NCT0021313
Autor:
Raffaele Palladino, P Montuori, V Brescia Morra, Marcello Moccia, Roberta Giordana, M P Sormani, Maria Triassi, R Lanzillo, Maria Grazia Fumo
Publikováno v:
European Journal of Public Health. 29
Background Multiple sclerosis (MS) is an heterogenous disease whose prevalence varies in Europe. Hereby, we aimed to estimate prevalence of MS in the Campania Region of Italy. Methods To identify individuals with MS living in the Campania Region of I
Autor:
M. P. Sormani, Cihat Uzunköprü, Murat Terzi, Husnu Efendi, Haluk Gümüş, Aslı Tuncer, Aksel Siva, Luca Carmisciano, Tuncay Gündüz, Melih Tutuncu, Ugur Uygunoglu, N. Kale Icen, Sedat Sen, Ömer Faruk Turan, Cavid Baba, Pinar Acar, Serkan Ozakbas, B. Petek Balci, Mesrure Koseoglu, Rana Karabudak, I. Gungor Dogan, Mehmet Fatih Yetkin, Irene Schiavetti, Semra Demir
Publikováno v:
Multiple Sclerosis and Related Disorders
Background: The pandemic of the new type of corona virus infection 2019 [Covid-19] also affect people with Multiple Sclerosis (pwMS). Currently, the accumulating information on the effects of the infection regarding the & nbsp;& nbsp;demographic and
Autor:
M. P. Sormani, Ralph H.B. Benedict, Jan Krasensky, Dana Horakova, Manuela Vaneckova, Tomas Kalincik, J. Blahova Dusankova, Eva Havrdova, Tomas Uher, Z. Seidl, Lukas Sobisek
Publikováno v:
European Journal of Neurology. 24:292-301
Background and purpose While impaired cognitive performance is common in multiple sclerosis (MS), it has been largely underdiagnosed. Here a magnetic resonance imaging (MRI) screening algorithm is proposed to identify patients at highest risk of cogn
Autor:
S La Gioia, B Forci, Sabrina Realmuto, Pietro Annovazzi, Arianna Sartori, Roberta Grasso, Cinzia Cordioli, M. L. Stromillo, R Lanzillo, B. Frigeni, Eleonora Cocco, Elisabetta Signoriello, Alessio Signori, Sandro Rossi, Giuseppe Fenu, M. P. Sormani, Damiano Baroncini, G. T. Maniscalco, Sarah Rasia, Jessica Frau
Background and purpose There is debate as to whether the apparent rebound after fingolimod discontinuation is related to the discontinuation itself or whether it is due to the natural course of highly active multiple sclerosis (MS). Our aim was to su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b04a20d6f78e48229ae131b2319b4386
http://hdl.handle.net/11567/925034
http://hdl.handle.net/11567/925034
Publikováno v:
Multiple Sclerosis and Related Disorders. 26:240-241